Identifiants & Marche
Ticker
AUPH
ISIN
CA05156V1022
CIK
0001600620
Bourse
NASDAQ
Devise
USD
Entreprise
Pays
CA
Siege
N/A
Fondee
N/A
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company is headquartered in Victoria, Canada.